Investors Financial Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Investors Financial Group’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-30,600	Closed	-$212K	–	205
2021 Q4	$212K	Sell	30,600 -4,000	-12%	-$33.6K	0.1%	186
2021 Q3	$329K	Buy	34,600 +5,000	+17%	+$46.9K	0.17%	142
2021 Q2	$296K	Buy	29,600 +400	+1%	+$4.45K	0.16%	155
2021 Q1	$342K	Buy	29,200 +11,000	+60%	+$185K	0.2%	129
2020 Q4	$650K	Sell	18,200 -3,566	-16%	-$61.5K	0.43%	64
2020 Q3	$301K	Sell	21,766 -93,494	-81%	-$1.4M	0.23%	110
2020 Q2	$1.9M	Buy	115,260 +53,005	+85%	+$631K	1.56%	13
2020 Q1	$529K	Buy	62,255 +45,122	+263%	+$631K	0.53%	58
2019 Q4	$390K	Buy	+17,133	New	+$244K	0.32%	80

Other funds holding LUMO

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Investors Financial Group's LUMO Position: Q1 2022 in Review

Investors Financial Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2022, closing a stake of 30,600 shares — an estimated $212K sold.

Investors Financial Group first reported a position in LUMO in Q4 2019 and held it in 9 quarters. The position peaked at $1.9M in Q2 2020. 36 funds tracked by Wall St. Rank hold LUMO as of Q1 2022.

Investors Financial Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Investors Financial Group sold 30,600 Lumos Pharma, Inc. Common Stock shares in Q1 2022, an estimated $212K.
Investors Financial Group first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2019 and held it in 9 quarters.
Investors Financial Group's Lumos Pharma, Inc. Common Stock position peaked at $1.9M in Q2 2020.
36 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2022.

Based on Investors Financial Group's 13F filing for Q1 2022.